NL-OMON44690已完成不适用
Tumor organoids: feasibility to predict sensitivity to treatment in cancer patients (TUMOROID trial) - TUMOROID
ederlands Kanker Instituut0 个研究点目标入组 665 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 665
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Patients with locally advanced (incurable) or metastatic colorectal, breast or lung (non-small cell) cancer who will start treatment with one of the regimens specified in the protocol.
- •- Measurable/evaluable disease
- •- Safe histologic tumor biopsy possible
- •- WHO 0-2
排除标准
- 未提供
研究者
相似试验
尚未招募
不适用
To assess the correlation chemotherapy effect on the tumor and in the patient derived organ like creation from pancreatic cancer cells.CTRI/2017/05/008512Tata Memorial Hospital20
招募中
不适用
An Organoid-based Functional Precision Medicine Trial in OsteosarcomaOsteosarcomaNCT06064682Jonsson Comprehensive Cancer Center40
招募中
不适用
Using Ex Vivo Tumoroids To Predict Immunotherapy Response In NSCLCNSCLC Stage IVLung CancerNSCLCNCT05332925Jun Zhang, MD, PhD25
招募中
不适用
*The prognostic and predictive value of Organoids from vena porta-derived Single CTCs in patients with primary ColorectAl canceR for development of liver metastases a feasibility study' (OSCAR)Colon CancerNL-OMON48875niversitair Medisch Centrum Utrecht30
进行中（未招募）
不适用
Identification of Predictive and Prognostic Markers for Lung Cancer With MetastasesPrimary TumorMetastasesLung CancerNCT02301858Janna Berg100